High Purity Pramipexole Powder CAS 191217-81-9: Advanced Chemical Synthesis for Parkinson's Disease and RLS Treatment

Discover the key benefits and applications of this vital pharmaceutical intermediate for neurological health.

Get a Quote & Sample

Key Advantages

Enhanced Efficacy for Neurological Disorders

Leveraging the properties of this dopamine agonist pharmaceutical intermediate can lead to improved outcomes in managing Parkinson's disease symptoms, as supported by research on pramipexole powder CAS 191217-81-9.

Stringent Quality Assurance

The GMP certified pramipexole powder guarantees that the material meets rigorous quality and safety standards, essential for pharmaceutical applications.

Versatile Application as a Pharmaceutical Intermediate

This high purity pramipexole dihydrochloride serves as a versatile building block for complex pharmaceutical syntheses targeting neurological conditions.

Key Applications

Parkinson's Disease Treatment

As a critical Restless Legs Syndrome API, pramipexole dihydrochloride is instrumental in alleviating the motor symptoms associated with Parkinson's disease, improving patient mobility and reducing tremors.

Restless Legs Syndrome Management

This high purity pramipexole powder CAS 191217-81-9 is widely used to treat Restless Legs Syndrome, providing relief from the uncomfortable sensations and urge to move the legs.

Dopamine Agonist Therapy

The product functions as a potent dopamine agonist, essential in therapies aimed at regulating dopamine levels in the brain for various neurological conditions.

Pharmaceutical Synthesis Intermediate

Its application extends to being a vital pharmaceutical intermediate, supporting the development of advanced drug formulations for neurodegenerative diseases.